0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

RESULTS OF TREATMENT OF RECURRING CONVULSIVE ATTACKS OF EPILEPSY

HADDOW M. KEITH, M.D.
Am J Dis Child. 1947;74(2):140-146. doi:10.1001/archpedi.1947.02030010148003.
Text Size: A A A
Published online

WHILE it is true that the therapeutic armamentarium for recurring convulsions (epilepsy) is better than it was before 1900, the principles of treatment have not changed much in the last few decades. Whereas from 1853 to 1912 bromide was the chief anticonvulsant drug, the relatively effective and nontoxic phenobarbital, introduced in 1912, a near relative "mebaral" (n-methylethylphenylbarbituric acid), and the even newer drug diphenylhydantoin sodium U. S. P. ("dilantin sodium") are now available. There are, of course, many other drugs that have been tried, but most physicians rely on these alone or in combination to control epileptic attacks.

In addition to drugs, the ketogenic diet1 has proved an effective method of treating children who have epileptiform convulsions.

Treatment of such children is especially important. Lennox,1a of Harvard Medical School, stated before a subcommittee of the Congress of the United States on May 24, 1945:

Because epilepsy is predominantly

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();